CTOs on the Move

Chartwell Law

www.chartwelllaw.com

 
With 29 offices located in Florida, Georgia, Illinois, Maryland, Massachusetts, Mississippi, Missouri, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee and Virginia, Chartwell Law attorneys offer a wide variety of legal services ranging from general liability and casualty defense, insurance coverage analysis and litigation, workers` compensation defense, employment law and workplace issues to high-stakes commercial litigation.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.chartwelllaw.com
  • 700 American Avenue Suite 303
    King of Prussia, PA USA 19406
  • Phone: 610.666.7700

Executives

Name Title Contact Details

Similar Companies

TIXiMED

TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes. Diabetes affects more than half a billion people worldwide. Those affected by Type 1 diabetes are dependent on multiple daily insulin injections or continuous insulin infusions to stay alive and manage their blood sugar. Oral anti-diabetic drugs are only approved for Type 2 diabetes, but can be associated with multiple side effects, underlining the need for novel and better oral diabetes medications for Type 1 and Type 2 diabetes. TXNIP inhibition has recently been demonstrated to be an effective and safe therapeutic approach in adults and children with recent onset Type 1 diabetes and TIX100 shows beneficial, anti-diabetic effects in 4 different mouse models. Advantages of TIX100 include oral availability, no associated hypoglycemia or weight gain, potent inhibition of detrimental TXNIP in human islets, and a favorable pharmacokinetic and safety profile. In addition, TIX100 inhibits excessive glucagon secretion and hepatic glucose production and protects against fatty liver. Thus, TIX100 holds promise for durable, weight-neutral improvement in glycemic control in Type 1 and Type 2 diabetes by targeting common underlying pathology and promoting patients own islet cell health.

Brandmovers

Brandmovers is a Atlanta, GA-based company in the Business Services sector.

sasd

sasd is a New York, NY-based company in the Business Services sector.

Alpha numeris

Alpha numeris inc. is a Sherbrooke, QC-based company in the Business Services sector.

Verbatim Advisory Group

Verbatim Advisory Group is a Maynard, MA-based company in the Business Services sector.